Protect yourself with

IXIARO® is a vaccine against the JE virus, used in people 2 months and older who live in or travel to areas where JE is common or seasonal. It is administered as two injections.

IXIARO® is a vaccine against the JE virus, used in people 2 months and older who live in or travel to areas where JE is common or seasonal. It is administered as two injections.

IXIARO® has a well-established efficacy and safety profile

IXIARO® was shown to offer effective protection against the JE virus in clinical trials conducted in adult (18 years old and older) and pediatric populations (2 months to 18 years old).

IXIARO® is generally well tolerated; very common side effects are:

– In adults (18 to 86 years old):

  • Headache
  • Muscle pain
  • Injection site pain/tenderness
  • Tiredness

– In children and adolescents (2 months to 18 years old):

  • Fever
  • Diarrhea
  • Influenza-like illness
  • Irritability
  • Injection site reactions

Side effects are usually mild and disappear within a few days.

IXIARO® Dosage and Administration in Adults

† Primary immunisation should be completed at least one week prior to potential exposure to Japanese Encephalitis virus.1

‡ In the event the primary series (Day 0 and Day 28) cannot be completed due to time constraints, a rapid immunization schedule (i.e. first dose at Day 0 and second dose at Day 7) in persons aged 18-65 years may be used.

Dosing and Administration in Pediatric Populations

† Primary immunisation should be completed at least one week prior to potential exposure to Japanese Encephalitis virus.1

‡ There are no data to support a rapid immunization schedule in children and adolescents (2 months to 17 years of age)

Your travel health specialist will advise of the need and timing for booster doses.

Please see Consumer Information leaflet for complete dosing and administration.

When is IXIARO® recommended?

Vaccination is recommended for travellers to JE endemic/epidemic areas during the risk season and who are spending

  • More than 30 days total in rural or urban risk areas (including individuals staying in urban areas who make intermittent short trips to rural risk areas)
  • Less than 30 days total in rural or urban risk areas, if they expect to have substantial activity outdoors (or indoors if indoor area does not exclude mosquitoes), especially during evening or night

Are you at risk?

Talk to your travel health specialist to see if IXIARO® is right for you.

Coverage and clinic finder

Are you covered?

You may be covered for the IXIARO® vaccine with your private insurance.
Contact your insurance provider and give the DIN (drug identification number) below to find out.

IXIARO® DIN: 02333279

Where to get IXIARO®?

By entering your postal code, you will be redirected to the website Vaccines411.ca, where you may find some of the nearest locations to get the vaccine.

Vaccines411.ca is a useful website which may help you find a location that offers IXIARO®. Other locations may also offer this vaccine. Talk to your doctor or healthcare professional, including your pharmacist.

Valneva is not associated with the website Vaccines411.ca. Valneva may not be held responsible for the publication, content or accuracy of the content featured on Vaccines411.ca and excludes all liability for any reliance placed upon, and for the consequences of any decision taken on the basis of, the content featured on such website. This link is provided for convenience only.

VALNEVA Canada Inc.
600-3535, Saint-Charles Blvd.
Kirkland (Montreal), Quebec
H9H 5B9

© 2019 VALNEVA Canada Inc.
All trademarks used under license.